Literature DB >> 21860842

Nonmedical treatment of patients with dementia.

Edmund Howe1.   

Abstract

This article reviews some nonmedical interventions that psychiatrists and other clinicians in the field of neuroscience can provide to their patients with dementia. The author discusses how clinicians can help patients and their caregivers understand the diagnosis causing the dementia (whether it be Alzheimer's, traumatic brain injury, Parkinson's disease, or vascular dementia) and help them to set realistic expectations of the treatment process for the patient and his or her loved ones. The author also reviews how clinicians can help caregivers modify their interactions with the patients when required to enhance not only the quality of life for the patient but the quality of life for the caregiver as well. Finally, the author reviews how clinicians can take on new initiatives that may help both the patients with dementia and their loved ones/caregivers when the patients are at the end stages of their disease.

Entities:  

Keywords:  Alzheimer's nonmedical; Dementia; caregivers; end-stage disease; initiatives; quality of life

Year:  2011        PMID: 21860842      PMCID: PMC3159541     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  38 in total

Review 1.  Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

Authors:  Uraina S Clark; Ronald A Cohen
Journal:  Curr Opin Investig Drugs       Date:  2010-08

2.  Depressive disorders in dementia.

Authors:  Luca Rozzini; Barbara Vicini Chilovi; Maddalena Riva; Marco Trabucchi; Alessandro Padovani
Journal:  Int J Geriatr Psychiatry       Date:  2011-06       Impact factor: 3.485

3.  Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.

Authors:  Parastoo Momeni; Mirdhu M Wickremaratchi; Jason Bell; Richard Arnold; Roger Beer; John Hardy; Tamas Revesz; James W Neal; Huw R Morris
Journal:  Clin Neurol Neurosurg       Date:  2010-08-12       Impact factor: 1.876

Review 4.  Pseudobulbar affect: the spectrum of clinical presentations, etiologies and treatments.

Authors:  Ariel Miller; Hillel Pratt; Randolph B Schiffer
Journal:  Expert Rev Neurother       Date:  2011-05-03       Impact factor: 4.618

5.  Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

Authors:  D Aarsland; K Bronnick; C Williams-Gray; D Weintraub; K Marder; J Kulisevsky; D Burn; P Barone; J Pagonabarraga; L Allcock; G Santangelo; T Foltynie; C Janvin; J P Larsen; R A Barker; M Emre
Journal:  Neurology       Date:  2010-09-21       Impact factor: 9.910

6.  Depression and neurocognitive performance in Portuguese patients infected with HIV.

Authors:  Miguel Bragança; António Palha
Journal:  AIDS Behav       Date:  2011-11

7.  Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease.

Authors:  O L Lopez; J T Becker; A S Wahed; J Saxton; R A Sweet; D A Wolk; W Klunk; S T Dekosky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-02-09       Impact factor: 10.154

Review 8.  Using non-pharmacological approaches for CJD patient and family support as provided by the CJD foundation and CJD insight.

Authors:  Florence J Kranitz; Deana M Simpson
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

9.  Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease.

Authors:  David Wilkinson; Henning Friis Andersen
Journal:  Dement Geriatr Cogn Disord       Date:  2007-07-04       Impact factor: 2.959

10.  Treatment initiatives for patients with Alzheimer's disease.

Authors:  Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.